基于18F-FDG PET/CT、影像征象及临床病理特征评估表现为实性结节的I期浸润性肺腺癌患者复发风险
该研究回顾性纳入2013年1月至2019年7月间接受18F-FDG PET/CT检查的230例I期浸润性肺腺癌(表现为实性结节)患者,评估代谢参数、CT征象及临床病理参数与无复发生存期(RFS)的关系。多因素Cox分析显示IASLC病理3级、空洞征、SUVmax及MTV为RFS的潜在独立预后因素,据此将患者分为高风险组和低风险组,两组5年RFS率分别为61.3%和94.1%(HR 6.04,95%CI 2.17-16.82,P<0.001)。
要点
- IASLC病理3级、空洞征、SUVmax及MTV为I期浸润性肺腺癌RFS的潜在独立预后因素。
- 高风险组(IASLC 3级、空洞征、SUVmax>3.9或MTV>5.4 cm3)5年RFS率为61.3%,低风险组为94.1%。
- 高风险组较低风险组RFS显著更差(HR 6.04,95%CI 2.17-16.82,P<0.001)。
核心结论
- 研究首次成功评估了表现为实性结节的I期浸润性肺腺癌患者的复发风险。
- 高风险组5年RFS率显著低于低风险组(61.3% vs 94.1%)。
- 研究可能有助于优化治疗策略并改善此类患者的生存获益。
研究设计与样本
- 回顾性纳入2013年1月至2019年7月间接受18F-FDG PET/CT检查的230例患者。
- 收集代谢参数包括SUVmax、平均标准摄取值、肿瘤代谢体积(MTV)及总肿瘤葡萄糖摄取。
- 采用Kaplan-Meier法评估无复发生存期(RFS),多因素Cox比例风险模型确定独立风险因素。
- 采用时间依赖ROC曲线计算代谢参数的最佳截断值。
主要发现
- 全部患者5年RFS率为71.7%。
- 多因素Cox分析显示IASLC病理3级(HR 3.96;95%CI 1.11-14.09)、空洞征(HR 5.38;95%CI 2.23-12.96)、SUVmax(HR 1.23;95%CI 1.13-1.33)及MTV(HR 1.05;95%CI 1.01-1.08)为RFS的潜在独立预后因素。
- 高风险组与低风险组RFS差异显著(HR 6.04;95%CI 2.17-16.82,P<0.001)。
- 低风险组5年RFS率为94.1%,高风险组为61.3%。
关键数值与推荐
- 高风险定义:IASLC病理3级、存在空洞征、SUVmax>3.9或MTV>5.4 cm3,其余为低风险。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stage I lung adenocarcinoma is a heterogeneous group. Previous studies have shown the prognostic evaluation value of PET/CT in this cohort; however, few studies focused on stage I invasive adenocarcinoma manifesting as solid nodules. This study aimed to evaluate the recurrence risk for patients with stage I invasive lung adenocarcinoma manifesting as solid nodules based on 18F-FDG PET/CT, CT imaging signs, and clinicopathological parameters. METHODS: We retrospectively enrolled 230 patients who underwent 18F-FDG PET/CT examination between January 2013 and July 2019. Metabolic parameters: maximum standard uptake value (SUVmax), mean standard uptake value, tumor metabolic volume (MTV), and total tumor glucose digestion were collected. Kaplan-Meier method was used to evaluate recurrence-free survival (RFS), and the multivariate Cox proportional hazards model was used to determine the independent risk factors associated with RFS. The time-dependent receiver operating characteristic curve (ROC) method was used to calculate the optimal cutoff value of metabolic parameters. RESULTS: The 5-year RFS rate for all patients was 71.7%. Multivariate Cox analysis revealed that the International Association for the Study of Lung Cancer Pathology Committee (IASLC) pathologic grade 3 [Hazard ratio (HR), 3.96; 95% Confidence interval (CI), 1.11-14.09], the presence of cavity sign (HR 5.38; 95% CI 2.23-12.96), SUVmax (HR 1.23; 95% CI 1.13-1.33), and MTV (HR 1.05; 95% CI 1.01-1.08) were potential independent prognostic factors for RFS. Patients with IASLC grade 3, the presence of cavity sign, SUVmax > 3.9, or MTV > 5.4 cm3 were classified as high risk, while others were classified as low risk. There was a significant difference in RFS between the high-risk and low-risk groups (HR 6.04; 95% CI 2.17-16.82, P < 0.001), and the 5-year RFS rate was 94.1% for the low-risk group and 61.3% for the high-risk group. CONCLUSIONS: We successfully evaluate the recurrence risk of patients with stage I invasive adenocarcinoma manifesting as solid nodules for the first time. The 5-year RFS rate in the high-risk group was significantly lower than in the low-risk group (61.3% vs. 94.1%). Our study may aid in optimizing therapeutic strategies and improving survival benefits for those patients.
引用
- Zheng X, Lin J, Xie J, et al. Evaluation of recurrence risk for patients with stage I invasive lung adenocarcinoma manifesting as solid nodules based on 18F-FDG PET/CT, imaging signs, and clinicopathological features. EJNMMI Res. 2023. PMID: 37261579. doi:10.1186/s13550-023-00998-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。